Also known as AAV. AAVs are small viruses used to transport genetic code to target cells and are commonly used in traditional gene therapy. Intellia is combining AAVs with LNPs to develop a CRISPR/Cas9-based approach for targeted gene insertion, which could overcome challenges of AAV gene therapy.